Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Bausch + Lomb has announced that it will acquire the dry eye drug Xiidra (lifitegrast ophthalmic solution) 5% from Novartis. Xiidra is an eye drop without steroids that has received specific approval for treating the signs and symptoms of dry…

Leber Congenital Amaurosis (LCA) is a rare genetic disorder that affects the retina, the part of the eye responsible for sensing light and sending visual signals to the brain. It is a severe form of retinal dystrophy, which means that…

What Is Dysphotopsia? Dysphotopsia, a term often sending shivers down the spine of even the most experienced ophthalmologists, refers to a spectrum of visual disturbances that patients may experience following cataract surgery. It is derived from the Greek words ‘dys’…

In Sweden, researchers have created a microscale device designed for implantation in the eye, opening up new paths for cell-based treatments for conditions like diabetes. Developed by a team from KTH Royal Institute of Technology and Karolinska Institutet, this 3D-printed…

Optical coherence tomography (OCT) stands as one of the most foundational and accurate tests for diagnosing eye diseases. While it excels in a detailed examination of individual eye structures, its effectiveness diminishes when applied to the early detection of subtle…

Parinaud oculoglandular syndrome is a relatively rare yet intriguing medical condition that intertwines ocular and glandular manifestations. Characterized by its distinct combination of eye-related symptoms and glandular involvement, this syndrome presents a unique challenge for both patients and medical professionals.…

Herpes Zoster Ophthalmicus (HZO), commonly known as shingles, is a viral disease characterized by a unilateral painful skin rash in one or more dermatome distributions of the fifth cranial nerve (trigeminal nerve), shared by the eye and ocular adnexa. Herpes…

VSY Biotechnology GmbH, an innovation-driven company with progressive R&D activities in ophthalmology, is readying to share the first clinical experiences of AcrivaUD Trinova Pro C Pupil Adaptive®, the first and only trifocal IOL that combines patented enhanced Sinusoidal Vision Technology…

What is Diffuse Lamellar Keratitis (DLK)? Diffuse Lamellar Keratitis, commonly referred to as DLK, is an inflammatory condition that can occur following LASIK (Laser-Assisted In Situ Keratomileusis) eye surgery. DLK is characterized by inflammation in the corneal flap, which is…

Light Adjustable Lens (LAL) technology is a groundbreaking advancement in the field of ophthalmology, offering a novel approach to vision correction and the treatment of cataracts. Unlike traditional intraocular lenses that are permanently fixed in their refractive power, LALs can…